Search for: "CORRECTIONAL HEALTH CARE GROUP, INC., et al." Results 41 - 60 of 75
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2022, 6:59 am by Robert Liles
Earlier this year, In March 2022, federal prosecutors charged the owner of two hospice agencies, a physician involved in the certification of medical necessity, and a marketer working for the hospices, with multiple counts of health care fraud. [read post]
4 Feb 2015, 6:54 pm by Schachtman
Salim Shah and his companies Sarfez Pharmaceuticals, Inc. and Sarfez USA, Inc. [read post]
25 Feb 2023, 6:50 pm by admin
was of course correct on this limited point, but generally in this field, peer review is worth a warm bucket of spit. [read post]
21 Jun 2013, 6:43 pm by Schachtman
Martin, et al., New York Evidence Handbook  318 (2d ed. 2002)). [read post]
8 Feb 2015, 2:38 pm by Schachtman
Writing in a law review for lawyers and judges might have led him to be more careful. [read post]
8 Feb 2015, 2:30 pm by Schachtman
Writing in a law review for lawyers and judges might have led him to be more careful. [read post]
20 Oct 2018, 8:50 am by Schachtman
Composite End Points Composite end points are typically defined, perhaps circularly, as a single group of health outcomes, which group is made up of constituent or single end points. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
August 2021 FDA Recalls Spectrum IQ Infusion Pumps have been issued an Urgent Medical Device Correction by Baxter International Inc. due to potential network connectivity errors. [read post]
1 Dec 2021, 1:29 pm by Kevin LaCroix
  There, the court addressed coverage under Pfizer’s 2004-2005 insurance tower for an underlying securities class action, Morabito, et. al v. [read post]
20 Oct 2011, 1:01 pm by Bexis
Sofamor Danek Group, Inc., 1999 WL 1132313 *7 (S.D. [read post]
19 Jun 2022, 4:44 pm by admin
The confusion of the two concepts has led to courts’ generally over-endorsing the black box of clinical judgment in health effects litigation. [read post]
25 Apr 2015, 11:03 am by Schachtman
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
10 Jun 2012, 1:09 pm by Schachtman
Didham, et al., “Suicide and Self-Harm Following Prescription of SSRIs and Other Antidepressants: Confounding By Indication,” 60 Br. [read post]